Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune Disease
- 1 October 2004
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 61 (10), 1613-1615
- https://doi.org/10.1001/archneur.61.10.1613
Abstract
Opinion from JAMA Neurology — Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune DiseaseKeywords
This publication has 14 references indexed in Scilit:
- A Controlled Trial of Natalizumab for Relapsing Multiple SclerosisThe New England Journal of Medicine, 2003
- Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trialThe Lancet, 2002
- Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effectsMultiple Sclerosis Journal, 2002
- Mechanisms of action of glatiramer acetate in multiple sclerosisNeurology, 2001
- Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligandNature Medicine, 2000
- Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosisAnnals of Neurology, 1999
- Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patientsJCI Insight, 1999
- Interferon beta in the treatment of multiple sclerosisNeurology, 1998
- Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.The Journal of Experimental Medicine, 1995
- Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.The Journal of Experimental Medicine, 1994